Coronary Artery Disease

Clinical Trial Finder

Many patients with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability

Conditions:   Myocardial Infarction;   Myocardial Ischemia;   Atherosclerosis;   Coronary Artery Disease;   Coronary Stenosis;   Heart Attack;   Multi Vessel Coronary Artery Disease
Interventions:   Diagnostic Test: PET-MRI;   Procedure: Optical Coherence Tomography
Sponsors:   Maastricht University Medical Center;   VieCuri Medical Centre;   Stichting de Weijerhorst
Not yet recruiting - verified August 2017

Diagnostic Performance of Coronary CT Angiography With CT FFR in Kidney Transplantation Candidates

Conditions:   Coronary Artery Disease;   Computed Tomography
Intervention:   Diagnostic Test: CT FFR (HeartFlow)
Sponsors:   Stanford University;   Siemens Medical Solutions
Not yet recruiting - verified August 2017

Endothelial and Microvascular Functions in Patients With Myocardial Ischemia

Condition:   Microcirculation; Biomarkers; Myocardial Ischemia
Intervention:  
Sponsors:   Rio de Janeiro State University;   Camillo L.C. Junqueira;   Esmeralci Ferreira;   Maria das Graças C. Souza;   Eliete Bouskela
Completed - verified August 2017

Duration of Dual Anti-Platelet Therapy (DUAL-ACS2)

Conditions:   Acute Coronary Syndrome;   Coronary Artery Disease
Interventions:   Other: 3 months dual anti-platelet therapy;   Other: 12 months dual anti-platelet therapy
Sponsors:   University of Edinburgh;   British Heart Foundation
Not yet recruiting - verified August 2017

ConnectedHeartHealth - Heart Failure Readmission Intervention

Conditions:   Diabetes Mellitus;   Coronary Artery Disease;   Heart Failure
Intervention:   Behavioral: Ambio Health Remote Monitoring
Sponsors:   LifeBridge Health;   American Heart Association (AHA)
Recruiting - verified August 2017

Safety and Efficacy of Multivessel Minimally Invasive Coronary Artery Bypass Graft Surgery

Condition:   Ischemic Heart Disease
Intervention:   Procedure: minimal invasive coronary artery bypass graft surgery
Sponsor:   Mohammed Farouk Abdel Hafez
Not yet recruiting - verified August 2017

GLOBAL LEADERS Adjudication Sub-Study

Conditions:   Coronary Artery Disease;   Platelet-aggregation Inhibitors
Intervention:  
Sponsors:   University Hospital Inselspital, Berne;   European Cardiovascular Research Center
Active, not recruiting - verified August 2017

Effectiveness of a Psychoeducational Group Intervention in Patients With Depression and Physical Comorbidity

Condition:   Depressive Disorder
Intervention:   Behavioral: Group psychoeducation
Sponsors:   Jordi Gol i Gurina Foundation;   Carlos III Health Institute
Not yet recruiting - verified August 2017

Prognostic Value of CT dynamIc Myocardial Perfusion in Patients With Obstructive Coronary Artery Stenosis

Condition:   CT Perfusion
Interventions:   Diagnostic Test: CTA CTP;   Diagnostic Test: CTA
Sponsors:   Chinese Academy of Medical Sciences, Fuwai Hospital;   Peking Union Medical College Hospital;   Shanghai Jiao Tong University Affiliated Sixth People’s Hospital;   Guangdong General Hospital;   Tianjin Medical University General Hospital
Recruiting - verified August 2017

A Case-control Study to Assess the Association Between Facial Characteristics and Coronary Artery Diseases

Condition:   Coronary Artery Disease
Intervention:   Other: Facial characteristics
Sponsor:   China National Center for Cardiovascular Diseases
Recruiting - verified August 2017

Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot Study

Condition:   Myocardial Infarction
Interventions:   Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg
Sponsor:   Collegium Medicum w Bydgoszczy
Recruiting - verified August 2017

Pediatric Myocardial Protection With Potassium Cardioplegia

Condition:   Cardioplegia
Interventions:   Drug: custodiol;   Drug: Cold blood cardioplegia (large volume);   Drug: Cold blood cardioplegia (small volume)
Sponsor:   Assiut University
Not yet recruiting - verified August 2017

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI

Condition:   ST Segment Elevation Myocardial Infarction
Interventions:   Drug: Alprostadil;   Drug: Nicorandil;   Drug: Nitroglycerin
Sponsors:   RenJi Hospital;   Shanghai 10th People's Hospital;   Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine;   Shanghai 6th People's Hospital;   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;   Ruijin Hospital
Not yet recruiting - verified August 2017

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI

Conditions:   ST Segment Elevation Myocardial Infarction;   Percutaneous Coronary Intervention
Interventions:   Drug: Cangrelor;   Other: Placebo
Sponsors:   University of Florida;   Chiesi Farmaceutici S.p.A.
Not yet recruiting - verified August 2017

Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon

Condition:   Coronary Restenosis
Interventions:   Combination Product: Sirolimus coated balloon;   Combination Product: Paclitaxel coated balloon
Sponsor:   University Hospital, Saarland
Recruiting - verified August 2017

Secondary PRevention Intervention by a Nursing Guide Program (SPRING)

Conditions:   Acute Coronary Syndrome;   Nutrition;   Physical Activity
Intervention:   Behavioral: INTERVENTION GROUP
Sponsor:   University Hospital A Coruña
Active, not recruiting - verified August 2017

Index of Microcirculatory Resistance After Immediate Versus Deferred Stenting in Patients With Acute Myocardial Infarction

Condition:   Acute Myocardial Infarction
Intervention:   Procedure: Deferred stenting
Sponsor:   Sejong General Hospital
Recruiting - verified August 2017

COmprehensive Remote Ischemic Conditioning in Myocardial Infarction

Condition:   Myocardial Infarction, Anterior Wall
Intervention:   Device: comprehensive remote ischaemic conditioning
Sponsors:   China National Center for Cardiovascular Diseases;   Chinese Academy of Medical Sciences
Recruiting - verified August 2017

Subclinical Cardiovascular Disease in Psoriatic Disease

Conditions:   Cardiovascular Diseases;   Myocardial Infarction;   Atherosclerotic Cardiovascular Disease;   Thrombotic Vascular Disease
Intervention:   Drug: Aspirin and/or Atorvastatin
Sponsor:   New York University School of Medicine
Recruiting - verified August 2017

Transfusion Trigger After Operations in High Cardiac Risk Patients

Conditions:   Myocardial Infarction;   Coronary Revascularization;   Acute Renal Failure
Intervention:   Procedure: Blood Transfusion
Sponsor:   VA Office of Research and Development
Not yet recruiting - verified August 2017

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Condition:   Homozygous Familial Hypercholesterolemia
Intervention:   Device: HDL Therapeutics PDS-2 System
Sponsors:   HDL Therapeutics;   MedStar Heart and Vascular Institute
Not yet recruiting - verified August 2017

Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI)

Conditions:   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions:   Drug: Enoxaparin (Staged-dose PCI Group);   Drug: Enoxaparin (Single-dose PCI Group);   Drug: Enoxaparin (High-dose Group);   Drug: Enoxaparin (Standard-dose Group)
Sponsor:   Peking Union Medical College Hospital
Recruiting - verified August 2017

The Effect of GRAVITY on Physiological Measurements During Invasive Coronary Angiography and Intervention

Condition:   Coronary Artery Disease
Intervention:  
Sponsors:   Basildon and Thurrock University Hospitals NHS Foundation Trust;   Anglia Ruskin University
Recruiting - verified August 2017

Hybrid Coronary Revascularization Trial

Condition:   Coronary Artery Disease
Interventions:   Procedure: Hybrid Coronary Revascularization;   Device: Hybrid Coronary Revascularization;   Device: Percutaneous Coronary Intervention
Sponsors:   Emilia Bagiella;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified August 2017

Evolving Routine Standards of FFR Use

Condition:   Myocardial Ischemia
Interventions:   Device: fractional flow reserve performed;   Other: fractional flow reserve not performed
Sponsors:   University Hospital of Ferrara;   Società Italiana di Cardiologia Invasiva
Recruiting - verified August 2017

Effects of Interval Physical Training on Expiratory Flow Limitation in Recent Myocardial Infarction

Conditions:   Expiratory Flow Limitation;   Recent Myocardial Infarction
Interventions:   Other: Interval Training (IT);   Other: Inspiratory Muscle Training (IMT)
Sponsors:   Federal University of Uberlandia;   Universidade Federal de Sao Carlos
Not yet recruiting - verified August 2017

Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS

Conditions:   Aortic Valve Stenosis;   Hypertrophy, Left Ventricular
Intervention:   Procedure: Aortic valve intervention
Sponsors:   University of Edinburgh;   Sir Jules Thorn Charitable Trust
Recruiting - verified August 2017

Real-time Feedback of SYNTAX Score Category During Coronary Angiographies to Improve Appropriateness of Coronary Revascularization for Patients With Stable Coronary Artery Diseases: a Before-and-after Controlled Study

Conditions:   Syntax Score;   Appropriateness;   Coronary Revascularization
Intervention:   Diagnostic Test: real-time feedback of SYNTAX score category
Sponsor:   China National Center for Cardiovascular Diseases
Recruiting - verified August 2017

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Conditions:   Coronary Artery Disease;   Ischemic Heart Disease;   Non ST Segment Elevation Myocardial Infarction
Interventions:   Device: Orbital Atherectomy;   Device: Balloon
Sponsors:   Cardiovascular Systems Inc;   Cardiovascular Research Foundation, New York
Recruiting - verified August 2017

OCT Registry in Patients With STEMI During PPCI

Condition:   ST Elevation Myocardial Infarction
Intervention:  
Sponsor:   Harbin Medical University
Recruiting - verified August 2017

Influence of Training Intensity in Coronary Artery Disease

Condition:   Coronary Artery Disease
Intervention:   Other: Training intensity (workload) during ergospirometry
Sponsors:   Hasselt University;   Jessa Hospital
Recruiting - verified August 2017

EROSION II: OCT Guided PPCI in STEMI

Condition:   STEMI - ST Elevation Myocardial Infarction
Intervention:  
Sponsor:   Harbin Medical University
Recruiting - verified August 2017

Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation

Conditions:   Coronary Disease;   Coronary Stenoses
Interventions:   Device: quantitative coronary angiography guided coronary intervention with sirolimus-eluting Orsiro stent;   Device: intravascular ultrasound guided coronary intervention with sirolimus-eluting Orsiro stent
Sponsors:   CHEOL WHAN LEE, M.D., Ph.D;   Biotronik SE & Co. KG
Recruiting - verified August 2017

Validation of Epworth Richmond's Echocardiography Education Focused Year

Conditions:   Shock, Cardiogenic;   Cardiac Tamponade;   Pulmonary Embolism;   Hypovolemia
Intervention:   Behavioral: Epworth Richmond's Echocardiography Focused Year
Sponsors:   Epworth Healthcare;   University of Melbourne
Completed - verified August 2017

Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?

Conditions:   Type 2 Diabetes;   Left Ventricular Hypertrophy
Interventions:   Drug: Dapagliflozin;   Drug: Placebo
Sponsors:   University of Dundee;   NHS Tayside;   AstraZeneca
Recruiting - verified August 2017

Aspirin in Preventing Recurrence of Cancer in Patients With Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Condition:   Node Positive HER2 Negative Breast Cancer
Interventions:   Other: Placebo;   Drug: Aspirin
Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI);   United States Department of Defense;   Bayer
Recruiting - verified August 2017

Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine

Condition:   Unstable Angina Pectoris
Interventions:   Drug: Crushed ticagrelor followed by morphine;   Drug: Crushed ticagrelor, morphine,naloxone
Sponsor:   Collegium Medicum w Bydgoszczy
Recruiting - verified August 2017

Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine

Condition:   Unstable Angina Pectoris
Interventions:   Drug: Crushed ticagrelor followed by morphine;   Drug: Crushed ticagrelor, morphine,metoclopramide
Sponsor:   Collegium Medicum w Bydgoszczy
Recruiting - verified August 2017

FINE75+: 5 Year Follow up

Conditions:   Non ST Elevation Myocardial Infarction (NSTEMI);   Frailty
Intervention:   Other: This is an observational study
Sponsor:   Linkoeping University
Completed - verified March 2017

Evaluation of Infarct Size With 3D Rotational Angiography

Condition:   Myocardial Infarction
Interventions:   Device: 3D RA;   Device: MRI
Sponsor:   Hospices Civils de Lyon
Recruiting - verified August 2017

OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)

Condition:   High Blood Pressure
Interventions:   Other: HTN PRA App;   Other: Blood Sample
Sponsors:   University of Florida;   OneFlorida Clinical Research Consortium
Active, not recruiting - verified August 2017

Reducing Acute Coronary Syndrome Patient Delay

Condition:   Acute Coronary Syndrome
Interventions:   Behavioral: Text+Visual BCT-based intervention;   Behavioral: Text-only BCT intervention;   Behavioral: Leaflet information (control)
Sponsors:   Edinburgh Napier University;   University of Stirling;   University of Aberdeen;   University of Dundee;   The University of New South Wales
Recruiting - verified August 2017

Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction

Conditions:   Myocardial Infarction;   Angioplasty, Balloon, Coronary;   Platelet Aggregation Inhibitors
Interventions:   Drug: Prasugrel;   Drug: Ticagrelor
Sponsor:   Faculty Hospital Kralovske Vinohrady
Completed - verified August 2017

The Impact of Post Stenting Balloon Dilatation on Coronary Microcirculation in STEMI Patients Undergoing PPCI

Condition:   ST-elevation Myocardial Infarction (STEMI)
Intervention:  
Sponsors:   Basildon and Thurrock University Hospitals NHS Foundation Trust;   Anglia Ruskin University
Recruiting - verified August 2017

Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention

Conditions:   Coronary Artery Disease;   Diabetes Mellitus, Type 2
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Peking Union Medical College Hospital
Recruiting - verified July 2017

STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction

Condition:   Myocardial Infarction
Interventions:   Drug: Tenecteplase;   Drug: Clopidogrel;   Procedure: Coronary angiography;   Procedure: Primary PCI
Sponsors:   Katholieke Universiteit Leuven;   Boehringer Ingelheim;   Life Sciences Research Partners;   Fund for Clinical Cardiovascular Research at LRD
Recruiting - verified August 2017

Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year

Condition:   Stable Angina
Interventions:   Device: Bioresorbable vascular scaffold;   Device: Everolimus-eluting stent
Sponsors:   Institut d'Investigació Biomèdica de Bellvitge;   Fundació La Marató de TV3
Active, not recruiting - verified August 2017

CT COMPARE: CT COronary Angiography to Measure PlAque REduction

Condition:   Cardiovascular Disease
Interventions:   Drug: Rosuvastatin;   Drug: Atorvastatin
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 9, 2017

A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction

Condition:   Acute Myocardial Infarction
Interventions:   Biological: CSL_112;   Other: Placebo
Sponsor:   CSL Behring
Completed - verified August 2017

The Physiological Impact of CTO PCI on Coronary Pressure Measurements and Correlation in Donor Vessel

Conditions:   Acute Coronary Syndrome;   Coronary Artery Disease
Intervention:  
Sponsor:   Basildon and Thurrock University Hospitals NHS Foundation Trust
Recruiting - verified August 2017

Early Endoscopy for Acute Upper Gastrointestinal Bleeding in Acute Coronary Syndrome Patients

Condition:   Gastrointestinal Bleeding
Intervention:   Other: endoscopic hemostasis
Sponsor:   Far Eastern Memorial Hospital
Recruiting - verified August 2017

"Me and My Heart" Study

Condition:   Acute Coronary Syndrome
Interventions:   Device: Active group with MEMS;   Device: Active group without MEMS;   Device: Control group with MEMS;   Device: Control group without MEMS
Sponsor:   AstraZeneca
Recruiting - verified August 2017

Mild Therapeutic Hypothermia for Patients With Acute Coronary Syndrome and Cardiac Arrest Treated With PCI

Conditions:   Cardiac Arrest;   Acute Coronary Syndrome
Intervention:   Procedure: Mild Therapeutic Hypothermia (MHT)
Sponsor:   Jacek Kubica
Not yet recruiting - verified August 2017

Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

Condition:   Coronary Artery Disease, Hypercholesterolemia, Hypertension
Intervention:   Other: No intervention
Sponsor:   Pfizer
Recruiting - verified August 2017

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center
Recruiting - verified August 2017

Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform

Condition:   Coronary Artery Disease
Interventions:   Other: Intervention group;   Other: Control group
Sponsors:   Hasselt University;   Jessa Hospital
Recruiting - verified August 2017

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care drugs
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting - verified August 2017

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Condition:   Cost Sharing, Acute Coronary Syndrome
Intervention:   Other: Study voucher card
Sponsors:   AstraZeneca;   Duke Clinical Research Institute
Active, not recruiting - verified August 2017

Reversal of the Anti-platelet Effects of Ticagrelor

Condition:   Coronary Artery Disease
Interventions:   Drug: Ticagrelor;   Drug: Aspirin + Ticagrelor;   Drug: Control;   Drug: Aspirin + Ticagrelor
Sponsors:   The First Affiliated Hospital with Nanjing Medical University;   National Natural Science Foundation of China
Completed - verified August 2017

Study Comparing the MiStent SES Versus the XIENCE EES Stent

Condition:   Coronary Stenosis
Interventions:   Device: MiStent;   Device: XIENCE EES
Sponsors:   ECRI bv;   Micell Technologies;   Stentys
Active, not recruiting - verified August 2017

Stress Echocardiography Versus Exercise ECG (ExECG) in Women With Chest Pain

Condition:   Coronary Artery Disease
Interventions:   Procedure: Exercise ECG;   Procedure: Stress Echocardiography
Sponsor:   London North West Healthcare NHS Trust
Recruiting - verified March 2017

Statins at the Primary Care Level

Condition:   Dyslipidemia
Intervention:   Other: Educational Intervention
Sponsor:   Institute for Clinical Effectiveness and Health Policy
Completed - verified August 2017

Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease

Condition:   Microvascular Coronary Dysfunction
Interventions:   Other: Handgrip;   Other: Altitude simulation;   Other: Leg exercise
Sponsor:   Cedars-Sinai Medical Center
Recruiting - verified August 2017

Minority Health Genomics and Translational Research Bio-Repository Database (MH-GRID)-2.0

Condition:   Hypertension
Intervention:  
Sponsors:   National Human Genome Research Institute (NHGRI);   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified August 3, 2017

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Conditions:   Stroke;   Secondary Prevention
Interventions:   Drug: optional ASA as comedication;   Drug: placebo to ASA;   Drug: placebo to optional ASA as comedication;   Drug: placebo to dabigatran etexilate;   Drug: ASA 100 mg;   Drug: dabigatran etexilate
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2017

Exercise as a Life-long Medicine in Patients With Coronary Artery Disease

Conditions:   Cardiovascular Diseases;   Myocardial Infarction;   Angina (Stable)
Interventions:   Behavioral: high-intensity exercise training;   Behavioral: web-based follow-up program;   Behavioral: usual care
Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Levanger Hospital
Recruiting - verified August 2017

Observational Study of the Association Between Periodontal Disease and Cardiovascular Disease

Conditions:   Periodontal Disease;   Coronary Artery Disease
Intervention:  
Sponsor:   Texas Tech University Health Sciences Center
Completed - verified August 2017

Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly

Conditions:   Cardiomyopathy;   Coronary Artery Disease;   Congestive Heart Failure;   Myocardial Infarction
Interventions:   Device: Implantable Cardioverter Defibrillator;   Other: Optimal Medical Therapy
Sponsor:   VA Office of Research and Development
Recruiting - verified August 2017

Identification of Adverse Plaque Characteristics by Coronary MR Angiography

Condition:   Coronary Artery Disease
Intervention:   Other: Coronary MR Angiography (CMRA)
Sponsor:   Cedars-Sinai Medical Center
Active, not recruiting - verified August 2017

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting - verified August 2017

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified August 2017

Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)

Condition:   Acute Myocardial Infarction
Interventions:   Drug: Anakinra 100 mg;   Drug: Anakinra 100 mg;   Drug: Placebo
Sponsors:   Virginia Commonwealth University;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2017

ABSORB STEMI: the TROFI II Study

Condition:   Acute ST Segment Elevation Myocardial Infarction
Intervention:   Device: Percutaneous Coronary Intervention
Sponsors:   ECRI bv;   Abbott Vascular;   Terumo Europe N.V.
Active, not recruiting - verified August 2017

Intensive Prevention Program After Myocardial Infarction

Conditions:   Myocardial Infarction;   Prevention Harmful Effects
Interventions:   Behavioral: Intensive Prevention Program;   Other: Standard medical and interventional therapy
Sponsors:   Herzzentrum Bremen;   Oldenburger Forschungs- und Entwicklungsinstitut für Informatik (OFFIS).
Completed - verified August 2017

Parasternal Nerve Block in Cardiac Patients

Conditions:   Coronary Artery Disease;   Pain, Postoperative
Interventions:   Drug: Exparel;   Drug: Placebo
Sponsor:   Peter A Knight
Completed - verified August 2017

Myocardial Perfusion and Scarring in Congenital Heart Disease

Condition:   Congenital Heart Disease
Intervention:  
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   Children's Research Institute;   Suburban Hospital
Completed - verified August 4, 2017

Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

Condition:   Renal Transplant
Intervention:   Drug: Zortress® /Everolimus
Sponsor:   University of Kentucky
Withdrawn - verified August 2017

IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG

Conditions:   Myocardial Infarct;   Heart Failure
Intervention:   Procedure: Injection of stem cells at time of coronary artery bypass grafting
Sponsors:   Centre hospitalier de l'Université de Montréal (CHUM);   Miltenyi Biotec, Inc.;   Centre de Recherche du Centre Hospitalier de l'Université de Montréal;   Maisonneuve-Rosemont Hospital
Completed - verified July 2015

Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction

Condition:   Cardiovascular Disease
Intervention:   Procedure: Cardiac MRI
Sponsors:   Cedars-Sinai Medical Center;   National Heart, Lung, and Blood Institute (NHLBI);   University of Florida;   University of Pittsburgh
Active, not recruiting - verified August 2017

Risk Reduction in Coronary Heart Disease

Condition:   Coronary Heart Disease
Interventions:   Behavioral: smoking cessation;   Drug: betablocker, diuretics, ACEI, ARB,;   Drug: statins, ezetimibe;   Behavioral: training;   Biological: influenza vaccine;   Drug: metformin, glimepiride, insulin;   Behavioral: weight reduction
Sponsors:   Sorlandet Hospital HF;   Oslo University Hospital
Active, not recruiting - verified August 2017

Advantageous Predictors of Acute Coronary Syndromes Evaluation (APACE) Study

Conditions:   Myocardial Infarction;   Angina, Unstable
Intervention:  
Sponsors:   University Hospital, Basel, Switzerland;   Swiss National Science Foundation
Recruiting - verified August 2017

Myocardial Damage In Patients With Cerebral Infarction

Condition:   Ischemic Stroke
Intervention:  
Sponsors:   Danish Heart Foundation;   Fonden for Lægevidenskabelig Forskning for Fyns Amt.;   Novo Nordisk A/S;   AJ Andersen og Hustrus Fond;   Overlægerådet Legatudvalg;   Raimond and Dagmar Ringgård-Bohn's Foundation;   Bankdirektør Hans Stener og hustru Agnes Steners legat;   Odense University Hospital
Completed - verified August 2017